Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cancers|November 26, 2022
Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell LinesDeQuarius King, Muhammad G Khodary, Temesgen Samuel, et al.
Biomedical Journal of Scientific & Technical Research|April 15, 2024
An Integrative Genomics Approach for Associating Genetic Susceptibility with the Tumor Immune Microenvironment in Triple Negative Breast CancerJacob Elnaggar, Fern Tsien, Clayton Yates, et al.
Oncotarget|January 11, 2015
Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancersRitu Arora, David Schmitt, Balasubramanyam Karanam, et al.
Molecular Cancer|September 16, 2011
Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cellsJianjun Zhou, Honghe Wang, Virginetta Cannon, et al.
Infectious Agents and Cancer|October 14, 2011
Detecting gene-gene interactions in prostate disease in African American menR Renee Reams, Krishna Rani Kalari, Honghe Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2010
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapyMohamed O Abdalla, Prasanthi Karna, Hari Krishna Sajja, et al.
Plos One|December 16, 2017
Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survivalHenry J Henderson, Balasubramanyam Karanam, Rajeev Samant, et al.
Frontiers in Immunology|July 28, 2018
Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-MetabolismAnusha Angajala, Sangbin Lim, Joshua B Phillips, et al.
Frontiers in Oncology|August 29, 2022
Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patientsJoakin O Mori, Jason White, Isra Elhussin, et al.
Oncology Letters|January 2, 2023
Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD-L1 and MHC I in colon cancer cellsMohamed Hassan, Vu Trung, Deepa Bedi, et al.
Pageof 9